Gut Barrier Function based Probiotic Mechanism of Action (MOA) Study Service in Animal Models

Creative Bioarray is at the forefront of preclinical research, offering specialized services to illuminate the intricate mechanisms by which probiotics enhance gut barrier function. Our comprehensive animal model studies provide critical insights into the molecular and cellular interactions that underpin the health benefits of your probiotic candidates, enabling you to develop scientifically validated and commercially successful products. Request a quote

Fig.1 Animal models for probiotic mechanism of action (MOA) study. (Creative Biolabs Authorized)

Overview: The Imperative of Gut Barrier Integrity

The gut barrier, a complex and dynamic interface, plays a pivotal role in maintaining host health by selectively allowing nutrient absorption while preventing the translocation of harmful microbes, toxins, and undigested food components into the systemic circulation. A compromised gut barrier, often referred to as "leaky gut," is implicated in a wide range of health issues, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), metabolic disorders, allergies, and even neurological conditions. Probiotics are increasingly recognized for their ability to bolster gut barrier integrity. Understanding the precise Mechanism of Action (MOA) by which these beneficial microbes exert their effects is crucial for product development, regulatory approval, and successful market entry. At Creative Biolabs, we leverage state-of-the-art animal models and cutting-edge analytical techniques to unravel these complex MOAs.

Gut Barrier Probiotic MOA: Advanced Animal Model Services

Workflow

Fig.2 The workflow of the Gut Barrier for the probiotic MOA study in animal models. (Creative Biolabs original)

Service Details

Animal Models
Administration
Analysis
Samples
Deliverables
Turnaround Time

Animal Models

  • Animal Model Selection: Expert guidance on choosing the most appropriate animal model (e.g., mice, rats, germ-free models, specific disease models like DSS-induced colitis, diet-induced obesity models) to best recapitulate the human condition and MOA.

Probiotic Administration & Dosing

Various administration routes, including oral gavage, dietary supplementation, and drinking water.

Gut Barrier Function Assessment

  • In Vivo Permeability Assays
    • FITC-dextran Assay: Oral administration of fluorescently labeled dextran followed by quantification in serum to measure paracellular permeability ("leaky gut").
    • LPS Translocation: Measurement of circulating lipopolysaccharide (LPS), a bacterial endotoxin, as an indicator of increased gut permeability.
  • Ex Vivo Permeability Assays
    • Direct measurement of transepithelial electrical resistance (TEER) and solute flux (e.g., mannitol, FITC-dextran) across isolated intestinal segments, providing a direct assessment of barrier integrity.
  • Histopathological Analysis
    • H&E staining to assess tissue morphology, inflammation, and epithelial damage.
    • Specialized stains (e.g., AB-PAS for goblet cells/mucus) to evaluate mucus layer thickness and composition.
  • Immunohistochemistry/Immunofluorescence
    • Localization and quantification of tight junction proteins (e.g., occludin, claudin-1, ZO-1).
    • Assessment of mucin protein expression (e.g., MUC2).
    • Identification and quantification of immune cells (e.g., T cells, B cells, macrophages, dendritic cells).
  • Gene and Protein Expression Analysis (qPCR, Western Blot, ELISA)
    • Quantification of mRNA and protein levels of genes related to tight junctions, mucin production, inflammatory cytokines (e.g., TNF-α, IL-6, IL-10), and antimicrobial peptides.
    • Measurement of circulating biomarkers of gut barrier disruption (e.g., zonulin, diamine oxidase (DAO)).
  • Microbiota Analysis
    • 16S rRNA Gene Sequencing: Comprehensive analysis of gut microbial community composition and diversity (alpha and beta diversity).
    • Shotgun Metagenomics: Deeper insights into microbial functional potential, including metabolic pathways and gene content.
    • SCFA Profiling: Quantification of short-chain fatty acids in fecal samples and/or gut lumen.
  • Immune Response Profiling
    • Cytokine/Chemokine Analysis: Measurement of inflammatory and anti-inflammatory mediators in serum, tissue homogenates, and cell culture supernatants.
    • Flow Cytometry: Phenotyping and quantification of immune cell populations in gut lamina propria, Peyer's patches, mesenteric lymph nodes, and spleen.

Sample Information

  • Probiotic Strain(s) Information:
  • Full taxonomic identification (species, strain designation).
  • Viable cell count (CFU/g or CFU/mL) and storage conditions.
  • Product formulation (e.g., lyophilized powder, liquid suspension, encapsulated).
  • Any specific handling instructions (e.g., anaerobic conditions).
  • Safety Data: Relevant safety data or regulatory status, if available.
  • Background Research: Any preliminary in vitro or in vivo data related to your probiotic and its hypothesized MOA.

Deliverables

Upon completion of your study, you will receive a comprehensive package including:

Deliverable Components Content Specifications
Detailed Study Report A comprehensive document summarizing the study design, methods, raw data, statistical analysis, results, and conclusions.
High-Quality Figures and Graphs Visually compelling representations of key findings.
Raw Data Files All raw data in easily accessible formats (e.g., Excel, CSV).
Histology Slides and Images Digital images of stained tissue sections.

Turnaround Time

Typical turnaround times vary depending on the complexity and duration of the study, but generally range from 8 to 16 weeks from protocol finalization to final report delivery. We will provide a precise timeline in your customized proposal.

Contact Us Today for a Quote

Advantages of Partnering with Creative Biolabs

Specialized Expertise

A dedicated team of gastrointestinal physiologists, immunologists, microbiologists, and animal care specialists with extensive experience in gut barrier function and probiotic research.

State-of-the-Art Facilities

Advanced equipment for in vivo studies, molecular biology, histology, and Ussing chamber experiments.

Customized Solutions

Flexible study designs tailored to your unique research questions and product development needs.

Rigorous Scientific Approach

Adherence to the highest scientific and ethical standards, ensuring reproducible and reliable data.

Comprehensive Readouts

A wide array of assays to provide a holistic understanding of probiotic MOA on gut barrier function.

Cost-Effectiveness and Efficiency

Streamlined processes and in-house capabilities to accelerate your research while managing costs.

Regulatory Support

The data generated is suitable for supporting regulatory submissions and health claim substantiation.

Collaborative Partnership

We act as an extension of your research team, fostering open communication and collaborative problem-solving.

Fig.3 Advanced omics platforms for probiotic MOA study. (Creative Biolabs Authorized)

Applications

  • Probiotic and Synbiotic Product Development: Substantiating health claims related to gut health, digestive comfort, and immune modulation.
  • Functional Food and Nutraceutical Industry: Demonstrating the efficacy of ingredients designed to support gut barrier integrity.
  • Pharmaceutical and Biotech Companies: Investigating the impact of novel therapeutics on gut barrier function in various disease models.
  • Academic Research: Exploring fundamental mechanisms of gut barrier regulation and host-microbe interactions.

Mechanism of Action (MOA): How Probiotics Fortify the Gut Barrier

Probiotics can improve gut barrier function through multiple, often synergistic, mechanisms:

Enhancing Tight Junction Protein Expression and Function

Tight junctions are multiprotein complexes that seal the paracellular space between intestinal epithelial cells, regulating barrier permeability. Probiotics can upregulate the expression of key tight junction proteins (e.g., occludin, claudins, ZO-1), leading to a stronger and less permeable barrier.

Modulating Mucus Layer Production

The mucus layer, primarily composed of mucin proteins secreted by goblet cells, forms a crucial physical barrier protecting the epithelial cells from direct contact with luminal contents. Certain probiotic strains can stimulate mucin production and improve the quality of the mucus layer.

Producing Short-Chain Fatty Acids (SCFAs)

Probiotics, particularly those that ferment dietary fibers, produce SCFAs (e.g., butyrate, propionate, acetate). Butyrate is a primary energy source for colonocytes and plays a vital role in maintaining epithelial cell health and barrier function.

Inhibiting Pathogen Adhesion and Growth

Probiotics can competitively exclude pathogens from binding sites on the intestinal epithelium and produce antimicrobial substances (e.g., bacteriocins, organic acids, hydrogen peroxide) that inhibit the growth of harmful bacteria, thereby reducing inflammatory triggers that compromise the barrier.

Modulating Gut Immune Response

Probiotics can interact with host immune cells in the gut-associated lymphoid tissue (GALT), promoting a balanced immune response. This can involve increasing anti-inflammatory cytokines while decreasing pro-inflammatory cytokines, reducing chronic inflammation that can damage the gut barrier.

Maintaining Epithelial Cell Integrity and Viability

Some probiotics can directly support the health and survival of intestinal epithelial cells, preventing apoptosis and promoting cell proliferation and wound healing in the event of barrier damage.

Ready to uncover the powerful mechanisms behind your probiotic innovation? Contact us today for a free consultation and customized proposal.

FAQs

What animal models do you typically use for gut barrier studies?

We primarily utilize rodent models (mice and rats) due to their well-characterized gut physiology, genetic modifiability, and established disease models. We can also explore other models based on specific project requirements.

Can you help us design a study for a novel probiotic strain?

Absolutely. Our scientific team excels at designing bespoke studies for novel probiotic candidates, leveraging their extensive knowledge of gut physiology and microbial interactions.

How do you handle intellectual property (IP)?

All intellectual property generated from your study remains solely with your company. We operate under strict confidentiality agreements.

Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2025 Creative Biolabs. All Rights Reserved.

Inquiry Basket